Our findings reveal a significant association, with elevated EAAT3 levels prevalent in 47 out of 54 NSCLC samples, coinciding with increased expressions of RELA and the NF-κB signaling target gene, BAX (Fig. 6A–C). The gene discussed is NFKB1; the disease is non-small cell lung carcinoma.